New program helps breast cancer patients overcome hormone therapy hesitation
NCT ID NCT05465408
First seen Feb 28, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study tested a short, nurse-led program to help breast cancer survivors who were hesitant or delayed in starting hormone therapy. The program aimed to support patients in making informed decisions. The study enrolled 35 women and measured how feasible and acceptable the program was.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana-Farber Brigham Cancer Center - Foxborough
Foxborough, Massachusetts, 02035, United States
-
Dana-Farber Brigham Cancer Center at Milford Regional Medical Center
Milford, Massachusetts, 01757, United States
-
Dana-Farber Brigham Cancer Center with South Shore Hospital
Weymouth, Massachusetts, 02190, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Dana-Farber Cancer Institute - Merrimack Valley
Methuen, Massachusetts, 01844, United States
-
Dana-Farber Cancer Institute at St Elizabeth's Medical Center
Brighton, Massachusetts, 02135, United States
-
Dana-Farber/New Hampshire Onoclogy-Hematology
Londonderry, New Hampshire, 03053, United States
-
Emerson Hospital/MGH Cancer Center
Concord, Massachusetts, 01742, United States
-
Mass General at Newton Wellesley Hospital
Newton, Massachusetts, 02462, United States
-
Mass General at North Shore Cancer Center
Danvers, Massachusetts, 01923, United States
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.